Documentation Centre

 

 

  of 357 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Nonalcoholic fatty liver disease: An emerging driver of cardiac arrhythmia. Circ Res. 2021;128:1747-1765 November 30, 2021 Nonalcoholic fatty liver disease: An emerging driver of cardiac arrhythmia. Circ Res. 2021;128:1747-1765 Chen Z, Liu J, Zhou F, Li H, Zhang XJ, She ZG, Lu Z, Cai J, Li H Key Publications
NAFLD: Reporting histologic findings in clinical practice. Hepatology. 2021;73:2028-2038 October 25, 2021 NAFLD: Reporting histologic findings in clinical practice. Hepatology. 2021;73:2028-2038 Brunt EM, Kleiner DE, Carpenter DH, Rinella M, Harrison SA, Loomba R, Younossi Z, Neuschwander-Tetri BA, Sanyal AJ; American Association for the Study of Liver Diseases NASH Task Force Key Publications
Modulating the gut microbiota with dietary interventions to protect against cardiometabolic disease. Nat Rev Cardiol. 2021;18:305 October 18, 2021 Modulating the gut microbiota with dietary interventions to protect against cardiometabolic disease. Nat Rev Cardiol. 2021;18:305 Fernández-Ruiz I Key Publications
Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review. Eur J Clin Invest. 2021;51:e13479 October 12, 2021 Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review. Eur J Clin Invest. 2021;51:e13479 Zhang X, Asllanaj E, Amiri M, Portilla-Fernandez E, Bramer WM, Nano J, Voortman T, Pan Q, Ghanbari M. Key Publications
The long and winding road to target protein misfolding in cardiovascular diseases. Eur J Clin Invest. 2021;51:e13504 October 11, 2021 The long and winding road to target protein misfolding in cardiovascular diseases. Eur J Clin Invest. 2021;51:e13504 Diteepeng T, Del Monte F, Luciani M. Key Publications
Updating concepts on atherosclerotic inflammation: From pathophysiology to treatment. Eur J Clin Invest. 2021;51:e13467 October 11, 2021 Updating concepts on atherosclerotic inflammation: From pathophysiology to treatment. Eur J Clin Invest. 2021;51:e13467 Ministrini S, Carbone F, Montecucco F Key Publications
Do diet and microbes really 'PREDICT' cardiometabolic risks? Nat Rev Endocrinol. 2021;17:259-260 September 30, 2021 Do diet and microbes really 'PREDICT' cardiometabolic risks? Nat Rev Endocrinol. 2021;17:259-260 Cani PD, Van Hul M Key Publications
Triglyceride lowering by omega-3 fatty acids: a mechanism mediated by N-acyl taurines. J Clin Invest. 2021;131:e147558 August 25, 2021 Triglyceride lowering by omega-3 fatty acids: a mechanism mediated by N-acyl taurines. J Clin Invest. 2021;131:e147558 Bornfeldt KE Key Publications
PCSK9 and atherosclerosis: Looking beyond LDL regulation. Eur J Clin Invest. 2021;51:e13459 August 03, 2021 PCSK9 and atherosclerosis: Looking beyond LDL regulation. Eur J Clin Invest. 2021;51:e13459 Ragusa R, Basta G, Neglia D, De Caterina R, Del Turco S, Caselli C Key Publications
NAFLD and cardiometabolic risk factors: The liver fibrosis trajectory through the lens of biological interactions. Hepatology. 2021;73:479-482 July 14, 2021 NAFLD and cardiometabolic risk factors: The liver fibrosis trajectory through the lens of biological interactions. Hepatology. 2021;73:479-482 Pirola CJ, Sookoian S Key Publications

  of 357 Next page

Go to page: of